# OnCo record momelotinib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/momelotinib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "momelotinib" ;
  schema:name "Momelotinib"@en ;
  schema:description "Momelotinib is the JAK inhibitor designed for anaemic myelofibrosis patients: it can improve haemoglobin while shrinking the spleen."@en ;
  schema:url <https://onco.cc/drugs/momelotinib/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Momelotinib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q252602> ;
  schema:citation <https://doi.org/10.1016/S0140-6736(22)02036-0>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=momelotinib> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:modality "Small-molecule JAK1/JAK2/ACVR1 inhibitor" ;
  schema:alternateName "Ojjaara / Omjjara" ;
  onco:approval "US 2023: Intermediate/high-risk myelofibrosis with anaemia", "EU 2024: Myelofibrosis with moderate-to-severe anaemia" ;
  onco:cancers <https://onco.cc/cancers/myeloproliferative-neoplasms/>, <https://onco.cc/cancers/primary-myelofibrosis/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/jak2/>, <https://onco.cc/targets/jak1/>, <https://onco.cc/targets/acvr1/> ;
  onco:companies <https://onco.cc/companies/gsk/> .